{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:27:30Z","timestamp":1790296050199,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["12\/IA\/1667"],"award-info":[{"award-number":["12\/IA\/1667"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Type I interferons (IFN-I) and their cognate receptor, the IFNAR1\/2 heterodimer, are critical components of the innate immune system in humans. They have been widely explored in the context of viral infection and autoimmune disease where they play key roles in protection against infection or shaping disease pathogenesis. A false dichotomy has emerged in the study of IFN-I where interferons are thought of as either beneficial or pathogenic. This \u2018good or bad\u2019 viewpoint excludes more nuanced interpretations of IFN-I biology - for example, it is known that IFN-I is associated with the development of systemic lupus erythematosus, yet is also protective in the context of infectious diseases and contributes to resistance to viral infection. Studies have suggested that a shared transcriptomic signature underpins both potential resistance to viral infection and susceptibility to autoimmune disease. This seems to be particularly evident in females, who exhibit increased viral resistance and increased susceptibility to autoimmune disease. The molecular mechanisms behind such a signature and the role of sex in its determination have yet to be precisely defined. From a genomic perspective, several single nucleotide polymorphisms (SNPs) in the IFN-I pathway have been associated with both infectious and autoimmune disease. While overlap between infection and autoimmunity has been described in the incidence of these SNPs, it has been overlooked in work and discussion to date. Here, we discuss the possible contributions of IFN-Is to the pathogenesis of infectious and autoimmune diseases. We comment on genetic associations between common SNPs in IFN-I or their signalling molecules that point towards roles in protection against viral infection and susceptibility to autoimmunity and propose that a shared transcriptomic and genomic immunological signature may underlie resistance to viral infection and susceptibility to autoimmunity in humans. We believe that defining shared transcriptomic and genomic immunological signatures underlying resistance to viral infection and autoimmunity in humans will reveal new therapeutic targets and improved vaccine strategies, particularly in females.<\/jats:p>","DOI":"10.3389\/fimmu.2021.757249","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:55:31Z","timestamp":1638384931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature"],"prefix":"10.3389","volume":"12","author":[{"given":"Jamie A.","family":"Sugrue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nollaig M.","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"O\u2019Farrelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I Interferons in Infectious Disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.002","article-title":"Dynamic Control of Type I IFN Signalling by an Integrated Network of Negative Regulators","volume":"36","author":"Porritt","year":"2015","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161451","article-title":"Detection of Interferon Alpha Protein Reveals Differential Levels and Cellular Sources in Disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular Toll-Like Receptors","volume":"32","author":"Blasius","year":"2010","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I Interferon [Corrected] Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of Innate Immune Adaptor Proteins MAVS, STING, and TRIF Induces IRF3 Activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh318","article-title":"Regulation of the Type I IFN Induction: A Current View","volume":"17","author":"Honda","year":"2005","journal-title":"Int Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.22.6660","article-title":"Differential Viral Induction of Distinct Interferon-Alpha Genes by Positive Feedback Through Interferon Regulatory Factor-7","volume":"17","author":"Mari\u00e9","year":"1998","journal-title":"EMBO J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00053-4","article-title":"Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-Alpha\/Beta Gene Induction","volume":"13","author":"Sato","year":"2000","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0513","article-title":"Most Lymphoid Organ Dendritic Cell Types are Phenotypically and Functionally Immature","volume":"102","author":"Wilson","year":"2003","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051395","article-title":"Production of Type I Interferons: Plasmacytoid Dendritic Cells and Beyond","volume":"202","author":"Asselin-Paturel","year":"2005","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00778","article-title":"Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver\u2019s Seat","volume":"10","author":"Ali","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134529","article-title":"TLR3 Controls Constitutive IFN-\u03b2 Antiviral Immunity in Human Fibroblasts and Cortical Neurons","volume":"131","author":"Gao","year":"2021","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-Stimulated Genes: What Do They All do","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu Rev Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome V2.0: An Updated Database of Annotated Interferon-Regulated Genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.10.7316","article-title":"Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling","volume":"181","author":"Kaur","year":"2008","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.006","article-title":"Type 1 Interferons Induce Changes in Core Metabolism That Are Critical for Immune Function","volume":"44","author":"Wu","year":"2016","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA Sensing by the cGAS-STING Pathway in Health and Disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00306","article-title":"Type I Interferon in Human Autoimmunity","volume":"5","author":"Niewold","year":"2014","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2013.03.041","article-title":"Hepatitis C Virus Targets the Interferon-\u03b1 JAK\/STAT Pathway by Promoting Proteasomal Degradation in Immune Cells and Hepatocytes","volume":"587","author":"Stevenson","year":"2013","journal-title":"FEBS Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0769-8","article-title":"Broad Immune Activation Underlies Shared Set Point Signatures for Vaccine Responsiveness in Healthy Individuals and Disease Activity in Patients With Lupus","volume":"26","author":"Kotliarov","year":"2020","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191220","article-title":"Early Type I IFN Blockade Improves the Efficacy of Viral Vaccines","volume":"217","author":"Palacio","year":"2020","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Sci (80-)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.016","article-title":"A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection","volume":"181","author":"Casanova","year":"2020","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0238347","DOI":"10.1371\/journal.pone.0238347","article-title":"Natural Killer Cell Phenotype is Altered in HIV-Exposed Seronegative Women","volume":"15","author":"Zhao","year":"2020","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12720","article-title":"Exploration of Potential Mechanisms of Hepatitis C Virus Resistance in Exposed Uninfected Intravenous Drug Users","volume":"24","author":"Shawa","year":"2017","journal-title":"J Viral Hepat"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0391-5","article-title":"Constitutive Immune Mechanisms: Mediators of Host Defence and Immune Regulation","volume":"21","author":"Paludan","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01574.x","article-title":"Cytokine Profiles in High Risk Injection Drug Users Suggests Innate as Opposed to Adaptive Immunity in Apparent Resistance to Hepatitis C Virus Infection","volume":"19","author":"Warshow","year":"2012","journal-title":"J Viral Hepat"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING Pathway as a Therapeutic Target in Inflammatory Diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.05.024","article-title":"From Your Nose to Your Toes: A Review of SARS-CoV-2 Pandemic-Associated Pernio","volume":"141","author":"Arkin","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr Virus and Systemic Autoimmune Diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2883","article-title":"Genetic Associations in Type I Interferon Related Pathways With Autoimmunity","author":"Delgado-Vega","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41584-020-0384-6","article-title":"Positive Results for Anifrolumab in Phase III SLE Trial","volume":"16","author":"Onuora","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.1038\/s41598-021-87760-4","article-title":"Investigation of Type I Interferon Responses in ANCA-Associated Vasculitis","volume":"11","author":"Batten","year":"2021","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3897","article-title":"Heterogeneity of Autoimmune Diseases: Pathophysiologic Insights From Genetics and Implications for New Therapies","volume":"21","author":"Cho","year":"2015","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41590-018-0105-3","article-title":"Natural Variation in the Parameters of Innate Immune Cells is Preferentially Driven by Genetic Factors","volume":"19","author":"Patin","year":"2018","journal-title":"Nat Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714765115","article-title":"Distinctive Roles of Age, Sex, and Genetics in Shaping Transcriptional Variation of Human Immune Responses to Microbial Challenges","volume":"115","author":"Piasecka","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 Infection in Caucasian Individuals Bearing Mutant Alleles of the CCR-5 Chemokine Receptor Gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm860","article-title":"Human Susceptibility and Resistance to Norwalk Virus Infection","volume":"9","author":"Lindesmith","year":"2003","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197608052950602","article-title":"The Resistance Factor to Plasmodium Vivax in Blacks. The Duffy-Blood-Group Genotype, FyFy","volume":"295","author":"Miller","year":"1976","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Sci (80-)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the Human Genetic Architecture of COVID-19","year":"2021","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142274","article-title":"Functional IRF3 Deficiency in a Patient With Herpes Simplex Encephalitis","volume":"212","author":"Andersen","year":"2015","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01030-z","article-title":"A Global Effort to Dissect the Human Genetic Basis of Resistance to SARS-CoV-2 Infection","author":"Andreakos","year":"2021","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic Lupus: A Developing Paradigm of Disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2660(08)00601-9","article-title":"Common Genetic Variation and Human Disease","volume":"62","author":"Orr","year":"2008","journal-title":"Adv Genet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135308","article-title":"A \u201cSilent\u201d Polymorphism in the MDR1 Gene Changes Substrate Specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-Synonymous SNPs: Server and Survey","volume":"30","author":"Ramensky","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MR0420-152R","article-title":"Structural Integrity With Functional Plasticity: What Type I IFN Receptor Polymorphisms Reveal","volume":"108","author":"de Weerd","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102179","article-title":"A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection","volume":"188","author":"Sironi","year":"2012","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/rheumatology\/ket316","article-title":"Polymorphisms Within Toll-Like Receptors Are Associated With Systemic Lupus Erythematosus in a Cohort of Danish Females","volume":"53","author":"Laska","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0963","article-title":"Polymorphisms in the TLR3 Gene Are Associated With Risk for Type 1 Diabetes Mellitus","volume":"170","author":"Assmann","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The Toll-Like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis","volume":"188","author":"O\u2019Dwyer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00600","article-title":"Independent Replication on Genome-Wide Association Study Signals Identifies IRF3 as a Novel Locus for Systemic Lupus Erythematosus","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1086\/595563","article-title":"Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer","volume":"199","author":"Wang","year":"2009","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.03.020","article-title":"Functional Dissection of an IFN-\u03b1\/\u03b2 Receptor 1 Promoter Variant That Confers Higher Risk to Chronic Hepatitis B Virus Infection","volume":"51","author":"Zhou","year":"2009","journal-title":"J Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0426","article-title":"Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients","volume":"18","author":"Reyes-Gibby","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored  Am Soc Prev Oncol"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2005.02.010","article-title":"IFNAR1 and IFNAR2 Polymorphisms Confer Susceptibility to Multiple Sclerosis But Not to Interferon-Beta Treatment Response","volume-title":"J Neuroimmunol","author":"Leyva","year":"2005"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2015.09.050","article-title":"Association Analysis of Class II Cytokine and Receptor Genes in Vitiligo Patients","volume":"77","author":"Traks","year":"2016","journal-title":"Hum Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208154","article-title":"Influence of TYK2 in Systemic Sclerosis Susceptibility: A New Locus in the IL-12 Pathway","volume":"75","author":"L\u00f3pez-Isac","year":"2016","journal-title":"Ann Rheumatol Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9320-x","article-title":"Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn\u2019s Disease in the Japanese Population","volume":"29","author":"Sato","year":"2009","journal-title":"J Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1086\/428480","article-title":"Polymorphisms in the Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Genes are Associated With Systemic Lupus Erythematosus","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1038\/s41598-018-25282-2","article-title":"The Psoriasis-Protective TYK2 I684S Variant Impairs IL-12 Stimulated Pstat4 Response in Skin-Homing CD4+ and CD8+ Memory T-Cells","volume":"8","author":"Enerb\u00e4ck","year":"2018","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1903561116","article-title":"Homozygosity for TYK2 P1104A Underlies Tuberculosis in About 1% of Patients in a Cohort of European Ancestry","volume":"116","author":"Kerner","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01281-1","article-title":"A Neanderthal OAS1 Isoform Protects Individuals of European Ancestry Against COVID-19 Susceptibility and Severity","volume":"27","author":"Zhou","year":"2021","journal-title":"Nat Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ebdd2b","article-title":"OAS1: A Multiple Sclerosis Susceptibility Gene That Influences Disease Severity","volume":"75","author":"O\u2019Brien","year":"2010","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1006820","DOI":"10.1212\/WNL.0b013e3181ebdd2b","article-title":"Identification of a Sj\u00f6gren\u2019s Syndrome Susceptibility Locus at OAS1 That Influences Isoform Switching, Protein Expression, and Responsiveness to Type I Interferons","volume":"13","author":"Li","year":"2017","journal-title":"PloS Genet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1000321","DOI":"10.1371\/journal.ppat.1000321","article-title":"Genetic Variation in OAS1 is a Risk Factor for Initial Infection With West Nile Virus in Man","volume":"5","author":"Lim","year":"2009","journal-title":"PloS Pathog"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310239","article-title":"Sex-Specific Effects of TLR9 Promoter Variants on Spontaneous Clearance of HCV Infection","volume":"66","author":"Fischer","year":"2017","journal-title":"Gut"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136047","article-title":"TLR7 Dosage Polymorphism Shapes Interferogenesis and HIV-1 Acute Viremia in Women","volume":"5","author":"Azar","year":"2020","journal-title":"JCI Insight"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz966","article-title":"Ensembl 2020","volume":"48","author":"Yates","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1038\/s41467-019-11152-6","article-title":"Microbiota-Derived Acetate Protects Against Respiratory Syncytial Virus Infection Through a GPR43-Type 1 Interferon Response","volume":"10","author":"Antunes","year":"2019","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0225289","DOI":"10.1371\/journal.pone.0225289","article-title":"Two Common Disease-Associated TYK2 Variants Impact Exon Splicing and TYK2 Dosage","volume":"15","author":"Li","year":"2020","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13059-016-1098-6","article-title":"Adaptively Introgressed Neandertal Haplotype at the OAS Locus Functionally Impacts Innate Immune Responses in Humans","volume":"17","author":"Sams","year":"2016","journal-title":"Genome Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cell.2018.08.034","article-title":"Evidence That RNA Viruses Drove Adaptive Introgression Between Neanderthals and Modern Humans","volume":"175","author":"Enard","year":"2018","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.11.010","article-title":"The Ribonuclease L-Dependent Antiviral Roles of Human 2\u2032,5\u2032-Oligoadenylate Synthetase Family Members Against Hepatitis C Virus","volume":"587","author":"Kwon","year":"2013","journal-title":"FEBS Lett"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06605.x","article-title":"Single Nucleotide Polymorphism at Exon 7 Splice Acceptor Site of OAS1 Gene Determines Response of Hepatitis C Virus Patients to Interferon Therapy","volume":"26","author":"El Awady","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.95","article-title":"Reassessment of the Type I Diabetes Association of the OAS1 Locus","volume":"10","author":"Qu","year":"2009","journal-title":"Genes Immun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00439-011-1053-2","article-title":"Identification of a New Susceptibility Variant for Multiple Sclerosis in OAS1 by Population Genetics Analysis","volume":"131","author":"Cagliani","year":"2012","journal-title":"Hum Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e71047","DOI":"10.7554\/eLife.71047","article-title":"Endomembrane Targeting of Human OAS1 P46 Augments Antiviral Activity","volume":"10","author":"Soveg","year":"2021","journal-title":"Elife"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/ca428083-dbcb-476a-956c-d7bb6e317cf7","article-title":"Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main Selective Pressure Through Human Evolution","volume":"7","author":"Fumagalli","year":"2011","journal-title":"PloS Genet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nri3421","article-title":"Population Genetic Tools for Dissecting Innate Immunity in Humans","volume":"13","author":"Quintana-Murci","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrg2698","article-title":"From Evolutionary Genetics to Human Immunology: How Selection Shapes Host Defence Genes","volume":"11","author":"Barreiro","year":"2010","journal-title":"Nat Rev Genet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"a017798","DOI":"10.1101\/cshperspect.a017798","article-title":"Global Epidemiology of Tuberculosis","volume":"5","author":"Glaziou","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41467-017-02611-z","article-title":"A Proline Deletion in IFNAR1 Impairs IFN-Signaling and Underlies Increased Resistance to Tuberculosis in Humans","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/science.1167728","article-title":"Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes","volume":"324","author":"Nejentsev","year":"2009","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender Differences in Autoimmune Disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-011-1081-y","article-title":"Sex Differences in Disease Risk From Reported Genome-Wide Association Study Findings","volume":"131","author":"Liu","year":"2012","journal-title":"Hum Genet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0083-1","article-title":"The Role of Sex in the Genomics of Human Complex Traits","volume":"20","author":"Khramtsova","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-200708","article-title":"Impaired Type I and III Interferon Response to Rhinovirus Infection During Pregnancy and Asthma","volume":"67","author":"Forbes","year":"2012","journal-title":"Thorax"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501684","article-title":"Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-\u03b1 Production in Women","volume":"195","author":"Griesbeck","year":"2015","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/35047580","article-title":"X-Chromosome Inactivation: Counting, Choice and Initiation","volume":"2","author":"Avner","year":"2001","journal-title":"Nat Rev Genet"},{"key":"B96","doi-asserted-by":"publisher","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 Escapes X Chromosome Inactivation in Immune Cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw7317","article-title":"Conservation, Acquisition, and Functional Impact of Sex-Biased Gene Expression in Mammals","volume":"365","author":"Naqvi","year":"2019","journal-title":"Sci (80-)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.757249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:55:36Z","timestamp":1638384936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.757249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2021.757249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.757249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"757249"}}